Roche to present new data on neuromuscular portfolio at MDA 2025, highlighting advances in SMA and DMD treatments
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present new data at the Muscular Dystrophy Association (MDA) conference, 16-19 March, 2025, in Dallas, Texas, from… read more.
